Biogen, Eisai Alzheimers Drug Lecanemab Fast Tracked By Fda

Biogen, Eisai Alzheimer’s drug lecanemab fast tracked by FDA

FDA decision on experimental Alzheimer's drug expected this week

Eisai-Biogen's Alzheimer's treatment drug receives FDA approval

Alzheimer's drug decision day: FDA to decide on Biogen and Eisai treatments

CNBC Television

Alzheimer’s drug lecanemab receives accelerated approval from FDA

WFAA

FDA fast-tracks approval for Alzheimer's drug

CBS Evening News

U.S. FDA approves experimental Alzheimer's drug

FDA approves Biogen-Eisai Alzheimer’s drug, China in talks to make Pfizer Paxlovid generic

US FDA approves 1st new Alzheimer’s drug in nearly 20 years

FDA approves controversial Biogen Alzheimer's drug | DW News

FDA approves Alzheimer's drug Leqembi, paving way for broader Medicare coverage

CNBC Television

FDA Grants Full Approval For Alzheimer s Drug Despite Concerns

Forbes Breaking News

Biogen to seek FDA approval for Alzheimer's drug Aducanumab

CNBC Television

Eisai Update on Alzheimer's Disease

HPR

Alzheimer's drug shows promise in early results of study

New Alzheimer's drug shows promise in early results of study

Here's what the FDA's endorsement of the Alzheimer's drug Leqembi means for Biogen

CNBC Television

Major ongoing clinical trials in AD: aducanumab, donanemab & lecanemab

FDA grants accelerated approval for new Alzheimer's drug

WCNC

FDA grants accelerated approval to Alzheimer's drug